Aysha Kuhlor, RN, BA, CDONA/LTC
Director of Clinical Services
President, CT Chapter, NADONA
Saint Mary Home
West Hartford, CT
Judith McFarland, RN, CDONA
Director of Nursing Services
Secretary, NJ Chapter, NADONA
House of the Good Shepherd
Chronic constipation is highly prevalent in older individuals. Those residing in long-term care are at particular risk, due to additional chronic disease burdens, immobility, and/or functional limitations. Severe constipation is not a benign condition; it can dramatically impact quality of life and lead to serious medical problems such as stercoral ulcers and fecal impaction.
The management of chronic constipation involves a combination of provider and patient education, dietary or pharmacologic modifications, and the judicious use of laxatives, enemas, and other pharmacotherapies. This program will identify the barriers to optimal management of these patients from the perspective of nursing directors, and highlight effective strategies for overcoming them. Through collaborative efforts, nursing teams can help lessen the healthcare burdens attributable to chronic constipation and significantly improve the lives of the older adults in their care. Program Developer/Facilitator
. Target Audience
Nurses, Certified Nursing Assistants (CNAs), and home health aides caring for older adults.
Upon completion of this educational activity, the participant should be able to:
Review how to improve the evaluation of residents with chronic constipation.
Identify ways to improve the monitoring and recording of bowel movements in skilled nursing facilities in order to develop patient-specific care plans.
Describe effective ways to communicate and address issues related to chronic constipation within the nursing staff and among the entire clinical care team.
It is the policy of NADONA/LTC to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The faculty must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflict of interest is resolved by NADONA/LTC prior to accreditation of the activity.
Ms. Kuhlor and Ms. McFarland report that they have no relevant financial relationships to disclose. Credit Statements
Nursing Continuing Education: NADONA/LTC is an approved provider of continuing nursing education by Georgia Nurses Association, an accredited approver by the American Nurses Credentialing Centerís Commission on Accreditation #1088. This program provides 0.5 contact hour by NADONA/LTC.
Participants must successfully complete the post-test (80% or higher) and submit an evaluation to receive credit. A statement of credit will be available immediately if the post-test and evaluation are completed online or within 6 weeks if they are sent by mail.
Commercial Support Statements
Supported by an educational grant from Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals North America, Inc.
This educational activity may contain discussion of published and/or investigational uses of pharmacologic agents. Some uses may not have been approved by the FDA. The faculty has disclosed discussion of off-label use during the presentation. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.